Anatole Besarab

ResearcherPublications, citations & collaboration network

Anatole Besarab is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 276 works, 13,167 citations, an h-index of 56 and an i10-index of 145.

276

Works

13,167

Citations

h-index

145

i10-index

IDs:OpenAlex

How has Anatole Besarab's publication output changed over time?

ScholarIQpublication output · 1995–2016

Output grew200% over the shown period — from 1 works in 1995 to 3 in 2016.

199519982000200220082013201420152016

What are the most-cited papers on Anatole Besarab?

ScholarIQmost cited works

The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin

Anatole Besarab, W. Kline Bolton, Jeffrey K. Browne, Joan C. Egrie, Allen R. Nissenson, Douglas M. Okamoto, Steve J. Schwab, David A. Goodkin

New England Journal of Medicine. 19981,937 CitationsOPEN ACCESS

Anton N. Sidawy, Richard Gray, Anatole Besarab, Mitchell L. Henry, Enrico Ascher, Michael Silva, Arnold Miller, Larry A. Scher, Scott O. Trerotola, Roger T. Gregory, Robert B. Rutherford, K. Craig Kent

Journal of Vascular Surgery. 2002903 Citations

The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access

Anton N. Sidawy, Lawrence M. Spergel, Anatole Besarab, Michael Allon, William C. Jennings, Frank T. Padberg, M. Hassan Murad, Víctor M. Montori, Ann M. O’Hare, Keith D. Calligaro, Robyn Macsata, Alan B. Lumsden, Enrico Ascher

Journal of Vascular Surgery. 2008550 Citations

Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Iain C. Macdougall, Andreas J. Bircher, Kai‐Uwe Eckardt, Gregorio T. Obrador, Carol A. Pollock, Peter Stenvinkel, Dorine W. Swinkels, Christoph Wanner, Günter Weiß, Glenn M. Chertow, John W. Adamson, Tadao Akizawa, Stefan D. Anker, Michael Auerbach, Peter Bárány, Anatole Besarab, Sunil Bhandari, Ioav Cabantchik, Alan J. Collins, Daniel W. Coyne, Ángel L.M. de Francisco, Steven Fishbane, Sandrine Gaillard, Tomas Ganz, David Goldsmith, Chaim Hershko, Ewa A. Jankowska, Kirsten L. Johansen, Kamyar Kalantar‐Zadeh, Philip A. Kalra, Bertram L. Kasiske, Francesco Locatelli, Jolanta Małyszko, Gert Mayer, Lawrence P. McMahon, Ashraf Mikhail, Elizabeta Nemeth, Amy Barton Pai, Patrick S. Parfrey, Roberto Pecoits‐Filho, Simon D. Roger, Guy Rostoker, Jacques Rottembourg, Ajay Singh, Itzchak Slotki, Bruce Spinowitz, Der‐Cherng Tarng, Francesca Tentori, Jorge E. Toblli, Yusuke Tsukamoto, Nosratola D. Vaziri, Wolfgang C. Winkelmayer, David C. Wheeler, Elena Zakharova

Kidney International. 2016477 CitationsOPEN ACCESS

Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD

Robert Provenzano, Anatole Besarab, Chao Sun, Susan A. Diamond, John H. Durham, José L. Cangiano, Joseph R. Aiello, James E. Novak, Tyson Lee, Robert Leong, Brian K. Roberts, Khalil G. Saikali, Stefan Hemmerich, Lynda A. Szczech, Kin-Hung P. Yu, Thomas B. Neff

Clinical Journal of the American Society of Nephrology. 2016296 CitationsOPEN ACCESS

Related on ScholarIQ

University of Virginia

Institution

The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin

Paper

The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access

Paper

Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Paper

Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD

Paper